Abstract:Obesity presents in about 90% of the diabetic patients, a risk factor that makes them more susceptible to cardiometabolic disorders, particularly insulin resistance and ultimately T2 diabetes. Increased oxidative stress and specifically lipid peroxidation are known to be major pathogenic factors driving these disorders in obesity. We recently reported that diabetic patients were found to have significantly lower level of glutathione peroxidase 4 (GPx4)- an antioxidant selenoenzyme which neutralizes lipid peroxides. Carnosine, a histidine-containing dipeptide which is highly concentrated in muscle and brain, has shown a remarkable therapeutic potential for preventing diabetes and its complications when administered orally in experimental and clinical studies of obesity. The extent to which carnosine can mitigate these disorders in the presence of GPx4 deficiency is not known however, and this is critical to determining its efficacy in diabetes patients. To address this question, wild-type (WT) and GPx4+/− male were randomly assigned to either standard chow (CNTL) or high fat high sucrose diet (HFHS) for 16 weeks. Seven weeks after starting the diet, half of the HFHS diet groups received 80 mM carnosine oral carnosine supplementation in their drinking water. Glucose and insulin tolerance tests performed 8 weeks after starting the diet revealed that carnosine significantly improved glucose tolerance in obese WT (P<0.05) but not obese GPx4+/− mice. Interestingly, carnosine treatment did significantly improve insulin sensitivity in the GPx4+/− mice, and to a lesser extent the WT mice. At the molecular level, we observed that HFHS diet up-regulated GPx4 protein in cardiac tissue from WT but not GPx4+/− mice, and protein oxidation was significantly reduced with carnosine treatment in both genotypes. Collectively, these findings indicate that carnosine supplementation could potentially mitigate insulin resistance even in patients with compromised antioxidant capacity (e.g., diabetes). Further analysis is in progress to evaluate the effectiveness of carnosine supplementation on additional cardiometabolic complications that are associated with diet induced obesity. This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Carnosine Improves Cognitive Impairment Through Promoting SIRT6 Expression and Inhibiting Endoplasmic Reticulum Stress in a Diabetic Encephalopathy Model

Carnosine-based reversal of diabetes-associated cognitive decline via activation of the Akt/mTOR pathway and modulation of autophagy in a rat model of type 2 diabetes mellitus

Electroacupuncture Improves Learning and Memory Deficits in Diabetic Encephalopathy Rats by Regulating the Nrf2/HO-1 Pathway

The protective role of carnosine against type 2 diabetes‐induced cognitive impairment

Carnosine,carnosinase gene polymorphism and diabetic nephropathy

Protective effect of carnosine on subcortical ischemic vascular dementia in mice.

Explore the Mechanism of β-Asarone on Improving Cognitive Dysfunction in Rats with Diabetic Encephalopathy

Quercetin Protects Against Diabetic Encephalopathy Via SIRT1/NLRP3 Pathway in Db/db Mice

Protective effect of carnosine on cognitive impairment induced by subcortical ischemic vascular dementia

Carnosine Ameliorates Stress-Induced Glucose Metabolism Disorder in Restrained Mice.

Polysaccharide extracted from Sarcandra glabra residue attenuate cognitive impairment by regulating gut microbiota in diabetic mice

Protective Effect of Carnosine after Chronic Cerebral Hypoperfusion Possibly Through Suppressing Astrocyte Activation.

Danggui-Shaoyao-San improves cognitive impairment through inhibiting O-GlcNAc-modification of estrogen α receptor in female db/db mice

SIRT6 prevent chronic cerebral hypoperfusion induced cognitive impairment by remodeling mitochondrial dynamics in a STAT5-PGAM5-Drp1 dependent manner

<i>Caveolin-1</i> Alleviates Diabetes-Associated Cognitive Dysfunction Through Modulating Neuronal Ferroptosis-Mediated Mitochondrial Homeostasis

Metformin improves cognitive dysfunction through SIRT1/NLRP3 pathway-mediated neuroinflammation in db/db mice

Endoplasmic Reticulum Stress/autophagy Pathway is Involved in Diabetes-Induced Neuronal Apoptosis and Cognitive Decline in Mice.

Caveolin-1 alleviates diabetes-associated cognitive dysfunction through modulating neuronal ferroptosis-mediated mitochondrial homeostasis

2-Dodecyl-6-Methoxycyclohexa-2,5-Diene-1,4-Dione Ameliorates Diabetic Cognitive Impairment Through Inhibiting Hif3α and Apoptosis

L-Carnosine Stimulation of Coenzyme Q10 Biosynthesis Promotes Improved Mitochondrial Function and Decreases Hepatic Steatosis in Diabetic Conditions

Oral Carnosine Supplementation Restores Insulin Sensitivity but not Glucose Tolerance in Mice With Glutathione Peroxidase-4 Deficiency